| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.099 | 0.002 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.094 | 0.002 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.002 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |